MAI Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
MAI Capital Management's LLY Position: Q2 2026 in Review
MAI Capital Management increased its Eli Lilly (LLY) stake by 33% in Q2 2026, buying an estimated $31.9M and bringing the position to 127,320 shares worth $153M. The position accounts for 0.57% of the portfolio, ranked #36.
MAI Capital Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- MAI Capital Management held 127,320 shares of Eli Lilly worth $153M as of Q2 2026.
- MAI Capital Management bought 31,231 Eli Lilly shares in Q2 2026, an estimated $31.9M.
- Eli Lilly made up 0.57% of MAI Capital Management's portfolio in Q2 2026, its #36 holding.
- MAI Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.